Free Shipping on purchases over €100

Nivea Sun Ultra Light Face Fluid Triple Protection Fp50+, 40 ml

NIVEA SUN UV Face Triple Protection Fluid: Daily protection against UV rays, blue light and pollution. Ultra-light, non-greasy moisturising formula with Hyaluronic Acid. Instantly absorbed, sweat resistant and compatible with all skin types. Environmentally friendly.

SKU: NI4005900997791
-25%
Promo FD
17.20
€22.90

Pharmaceutical Care

Safe medication sales

Secure shipping

INFO AND TECHNICAL SPECIFICATIONS

NIVEA SUN UV Face Triple Protection Ultralight Fluid offers daily protection against 1. UV rays 2. This sunscreen protects healthy skin from the OUTSIDE against UVA/UVB rays and blue light, which cause skin damage and premature skin ageing. It also protects skin from the INSIDE* thanks to Licorice Extract. This powerful natural antioxidant stimulates the skin's natural protection to protect cells and act against pollution and its effects, such as oxidative stress. This ultra-light, non-greasy moisturising fluid with Hyaluronic Acid is instantly absorbed with an invisible effect on the skin - suitable for use before make-up and is sweat resistant. Provides a smooth and healthy skin appearance. Recommended for normal, combination and sensitive skin. Dermatologically tested skin compatibility. *NIVEA SUN is committed to minimising its impact on the environment. 76% biodegradable formula Ocean friendly:: no UV filters Octinoxate, Oxybenzone, Octocrylene and no microplastics Bottle and cap made from 50% recycled plastic (excluding label and nozzle) www.nivea.es/sostenibilidad NIVEA SUN UV Face is available for normal/mixed, normal/dry, sensitive and normal skin. Protection for everyone with NIVEA SUN Adults and Children.

Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.